Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy
Research Subject: Cancer
Author: Simona Pisanti, Cristina Borselli, Olimpia Oliviero
Publish Date: 2006
Endocannabinoids are now emerging as suppressors of key cell-signaling pathways involved in cancer cell growth, invasion, and metastasis. We have previously observed that the metabolically stable anandamide analog, 2-methyl-20-F-anandamide (Met-F-AEA) can inhibit the growth of thyroid cancer in vivo. Our hypothesis was that the anti-tumor effect observed could be at least in part ascribed to inhibition of neo-angiogenesis. Therefore, the aim of this study was to assess the anti-angiogenic activity of Met-F-AEA, to investigate the molecular mechanisms underlying this effect and whether Met-F-AEA could antagonize tumor-induced endothelial cell sprouting.
Download PDF
Other Research
-
Research
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
Cannabidiol (CBD), one of the main components of Cannabis sp., presents clinical and preclinical anx…
-
Research
Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice
Cannabidiol, a nonpsychoactive constituent of the Cannabis sativa plant, has been reported to act as…
-
Research
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine
Cocaine is a commonly abused illicit drug that causes significant morbidity and mortality. The most …
-
Research
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferat…
-
Research
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Cannabis extracts and several cannabinoids have been shown to exert broad antiinflammatory activitie…